NCT06279637

Brief Summary

This study will test the preliminary efficacy of a joint patient/informal caregiver telephone-delivered intervention that includes diabetes education; problem solving around social needs; and behavioral activation for older African Americans with poorly controlled type 2 diabetes by randomizing 100 patient/caregiver dyads to the Joint Home intervention (n=50) and usual care (n=50) arms. The aims of the study are: Aim 1: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) on patient clinical outcomes (hemoglobin A1c, blood pressure, and LDL-Cholesterol). Aim 2: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) Joint Home DM-BAT on patient quality of life. Aim 3: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) on caregiver quality of life and caregiver burden.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
2mo left

Started Mar 2024

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Mar 2024Jul 2026

First Submitted

Initial submission to the registry

February 19, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 28, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

March 4, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

July 29, 2025

Status Verified

July 1, 2025

Enrollment Period

2.4 years

First QC Date

February 19, 2024

Last Update Submit

July 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glycemic Control (Hemoglobin A1C [HbA1C])

    About 10cc of blood will be drawn by trained phlebotomists and sent to the lab for testing.

    Change in baseline HbA1C at 6 months post intervention follow-up

Study Arms (2)

Joint Home-DM-BAT Intervention

EXPERIMENTAL

A trained health educator will deliver the manualized Joint Home-DM-BAT intervention. Participants will receive 8-weekly sessions of diabetes education, problem solving around social needs, and behavioral activation via telephone; and 3 monthly booster sessions.

Behavioral: Joint Home-DM-BAT Intervention

Usual Care

ACTIVE COMPARATOR

Patients randomized to the usual care arm will receive weekly mailings of diabetes education modules for 8 weeks and monthly mailings for 3 months to match the weekly and monthly booster sessions.

Behavioral: Usual Care

Interventions

8 weekly sessions of telephone-delivered, manualized education on diabetes management, problem solving of social needs, and behavioral activation.

Joint Home-DM-BAT Intervention
Usual CareBEHAVIORAL

Diabetes education materials will be mailed weekly and monthly according to the booster schedule

Usual Care

Eligibility Criteria

Age50 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥50 years of age;
  • Self-identified as Black/African American;
  • Clinical diagnosis of T2DM and poorly controlled, defined as HbA1c ≥8% at the screening visit;
  • Able to communicate in English; and
  • Has an informal caregiver (family member or close friend willing to participate in the study for 6 months.
  • Willing to attend 4, one-hour sessions with the study participant;
  • Willing to support the study participant for study duration (6 months); and
  • Willing to complete brief baseline, 3- and 6-month assessments.

You may not qualify if:

  • Mental confusion at screening assessment suggesting significant dementia;
  • Alcohol or drug abuse/dependency at screening assessment;
  • Active psychosis or acute mental disorder at screening assessment; and
  • Life expectancy \<6 months at screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Aprill Z Dawson, PhD, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 19, 2024

First Posted

February 28, 2024

Study Start

March 4, 2024

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

July 29, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations